Impaired placental neovascularization in mice with pregnancy-associated hypertension

Laboratory Investigation

Volumn 88, Issue 4, 2008, Pages 416-429

  Furuya, Mitsuko ^a   Ishida, Junji ^b   Inaba, Saki ^b   Kasuya, Yoshitoshi ^a   Kimura, Sadao ^a   Nemori, Ryoichi ^c   Fukamizu, Akiyoshi ^b  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Fuji Film Life Science Laboratory   (Japan)

Author keywords

Angiotensin; Neovascularization; Placenta; Preeclampsia; Tissue remodeling; Transgenic mice

Indexed keywords

ANGIOTENSINOGEN; GELATINASE A; MESSENGER RNA; RENIN; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BLOOD PRESSURE; CONTROLLED STUDY; CONVULSION; DOWN REGULATION; FEMALE; GESTATION PERIOD; HISTOLOGY; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; MATERNAL HYPERTENSION; MATING; MICROVASCULATURE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERICYTE; PLACENTA CIRCULATION; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEINURIA; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; BASEMENT MEMBRANE; FEMALE; FETUS; GENE EXPRESSION; HYPERTENSION, PREGNANCY-INDUCED; INFARCTION; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE HYDROLASES; PERICYTES; PLACENTA; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 41149086258     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.7     Document Type: Article

References (48)

1. National high blood pressure education program working group on high blood pressure in pregnancy report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
2. Parham P. NK cells and trophoblasts: partners in pregnancy. J Exp Med 2004;200:951-955.
3. Hiby SE, Walker JJ, O'Shaughnessy KM, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004;200:957-965.
4. Hu Y, Dutz JP, MacCalman CD, et al. Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: a role for IFN-gamma. J Immunol 2006;177:8522-8530.
5. Kobashi G, Hata A, Shido K, et al. Association of a variant of the angiotensinogen gene with pure type of hypertension in pregnancy in the Japanese: implication of a racial difference and significance of an age factor. Am J Med Genet 1999;86:232-236.
6. van Dijk M, Mulders J, Poutsma A, et al. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet 2005;37:514-519.
7. Johnson MP, Fitzpatrick E, Dyer TD, et al. Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Mol Hum Reprod 2007;13:61-67.
8. Reynolds LP, Borowicz PP, Vonnahme KA, et al. Animal models of placental angiogenesis. Placenta 2005;26:689-708.
9. Takimoto E, Ishida J, Sugiyama F, et al. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 1996;274:995-998.
10. Saito T, Ishida J, Takimoto-Ohnishi E, et al. An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation. FASEB J 2004;18:388-390.
11. Takimoto-Ohnishi E, Saito T, Ishida J, et al. Differential roles of renin and angiotensinogen in the feto-maternal interface in the development of complications of pregnancy. Mol Endocrinol 2005;19:1361-1372.
12. Kasai A, Shintani N, Oda M, et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 2004;325:395-400.
13. Boven LA, Middel J, Breij EC, et al. Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines. J Neurovirol 2000;6:382-389.
14. Furuya M, Ishikura H, Nemori R, et al. Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography. Hum Pathol 2001;32:163-168.
15. Adamson SL, Lu Y, Whiteley KJ, et al. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 2002;250:358-373.
16. Johansen M, Redman CWG, Wilkins T, et al. Trophoblast deportation in human pregnancy - its relevance for pre-eclampsia. Placenta 1999;20:531-539.
17. Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996;87:1161-1169.
18. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996;87:1171-1180.
19. Imhof BA, Aurrand-Lions M. Angiogenesis and inflammation face off. Nat Med 2006;12:171-172.
20. O'Dowd BF, Heiber M, Chan A, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993;136:355-360.
21. Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998;251:471-476.
22. Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 2004;118:119-125.
23. Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001;99:87-92.
24. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-658.
25. Kraus FT, Redline RW, Gersell DJ, et al. Placental Pathology. AFIP: Washington, DC, 2004, pp 1-22.
26. Teesalu T, Masson R, Basset P, et al. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation. Dev Dyn 1999;214:248-258.
27. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet 2001;2:538-548.
28. Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002;160:1405-1423.
29. Lewis SH, Benirschke K. Placenta. In: Sternberg SS (ed). Placenta In Histology for Pathologist, 2nd edn. Lippincott-Raven: New York, 1997, pp 961-996.
30. Knock GA, Sullivan MH, McCarthy A, et al. Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J Pharmacol Exp Ther 1994;271:1007-1015.
31. Kalenga MK, Thomas K, de Gasparo M, et al. Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension. Clin Endocrinol (Oxfor 1996;44:429-433.
32. Hanssens M, Keirse MJ, Spitz B, et al. Angiotensin II levels in hypertensive and normotensive pregnancies. Br J Obstet Gynaecol 1991;98:155-161.
33. Gant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682-2689.
34. AbdAlla S, Lother H, el Massiery A, et al. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001;7:1003-1009.
35. Wallukat G, Homuth V, Fischer T, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999;103:945-952.
36. Dunk C, Shams M, Nijjar S, et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 2000;156:2185-2199.
37. Zhang EG, Smith SK, Baker PN, et al. The regulation and localization of angiopoietin-1, -2, and their receptor Tie2 in normal and pathologic human placentae. Mol Med 2001;7:624-635.
38. Tsiamis AC, Morris PN, Marron MB, et al. Vascular endothelial growth factor modulates the Tie-2: Tie-1 receptor complex. Microvasc Res 2002;63:149-15827.
39. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592-1594.
40. Fernandez-Catalan C, Bode W, Huber R, et al. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO J 1998;17:5238-5248.
41. Ishida J, Hashimoto T, Hashimoto Y, et al. Regulatory roles for APJ, a seven-transmembrane receptor related to AT1, in blood pressure in vivo. J Biol Chem 2004;279:26274-26279.
42. Iwanaga Y, Kihara Y, Takenaka H, et al. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol 2006;41:798-806.
43. Zhong JC, Huang DY, Liu GF, et al. Effects of all-trans retinoic acid on orphan receptor APJ signaling in spontaneously hypertensive rats. Cardiovasc Res 2005;65:743-750.
44. Zheng J, Bird IM, Chen DB, et al. Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide. J Physiol 2005;565:59-69.
45. Morita K, Sasaki H, Furuse M, et al. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 1999;147:185-194.
46. Hashimoto Y, Ishida J, Yamamoto R, et al. protein-coupled APJ receptor signaling induces focal adhesion formation and cell motility. Int J Mol Med 2005;16:787-792.
47. Kharfi A, Giguère Y, Sapin V, et al. Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. Clin Biochem 2003;36:323-331.
48. Granger JP, Alexander BT, Bennett WA, et al. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens 2001;14:178S-185S.